Key facts
- This page summarizes Ivan Howard's Form 4 filing for Tenon Medical, Inc. (TNON).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 May 2022, 17:27.
Ivan Howard - 12 May 2022 Form 4 Insider Report for Tenon Medical, Inc. (TNON)
- Reporting relationship
- Director
- Issuer ticker
- TNON
- Reported as of
- 12 May 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 May 2022, 17:27:36 UTC
- Prior SEC filing
- 26 Apr 2022
- Next SEC filing
- 24 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ivan Howard
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ivan Howard filed Form 4 for Tenon Medical, Inc. (TNON) on 16 May 2022.
Change
- Previous filing in this sequence was filed on 26 Apr 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TNON
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 18,623
- Date
- 12 May 2022
- Ownership
- Direct
- Underlying class
- COMMON STOCK
- Underlying amount
- 18,623
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Ivan Howard is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 2 footnotes
Footnote F1
These units vest for 3 years on an annual basis.
Footnote F2
N/A